Skip to main content

Rehabilitation and palliation of patients with bronchial cancer

  • Chapter
Rehabilitation and palliation of cancer patients
  • 830 Accesses

Abstract

The aims of after-care in the follow-up are to lengthen survival time and to improve quality of life as well (fig. 1.1). Recurrence prevention, early detection of recurrences and therapy of disease recurrence (potentially curative follow-up measures) serve to lengthen survival time (fig. 1.3). Supportive, rehabilitative and palliative measures serve to improve quality of life and activities of daily living (fig. 1.2).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  • — AARC Clinical Practice Guideline (2002) Pulmonary rehabilitation. Respir Care 47(5): 617–25

    Google Scholar 

  • — Abid SH, Malhotra V, Perry MC (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13: 242–8

    Article  PubMed  CAS  Google Scholar 

  • — Abrahm J (2004) Assessment and treatment of patients with malignant spinal cord compression. J Support Oncol 2: 377–401

    PubMed  Google Scholar 

  • — Algar FJ, Alvarez A, alvatierra A et al. (2002) Predicting pulmonary complications after pneumonectomy for lung cancer. Eur J Cardiothorac Surg 2003; 23: 201–8

    Article  Google Scholar 

  • — Ampil F, Caldito G (2006) Radiotherapy for palliation of lung cancer in patients with compromised hearts. J Pall Med 9,2: 241–2

    Article  CAS  Google Scholar 

  • — Akira M, Ishikawa H, Yamamoto S (2002) Drug-induced Pneumonitis: Thin-Section CT Findings in 60 Patients Radiology 224: 852–60

    Article  PubMed  Google Scholar 

  • — Arbeiter K, Prakash U, Tazelaar H et al. (1999) Radiation-Induced Pneumonitis in the “Non-Irradiated” Lung. Mayo Clin Proc. 74: 27–36

    Article  Google Scholar 

  • — Aspinal F, Hughes R, Higginson I et al. (2002) A user’s guide to the palliative care outcome scale. Palliative care & policy publications. Kings College, London

    Google Scholar 

  • — Barat M, Franchignoni F (2004) Assessment in physical medicine and rehabilitation. Maugeri Foundation Books, PI-ME Press Pavia

    Google Scholar 

  • — Bausewein C, Fegg M, Radbruch L et al. (2005) Validation and clinical application of the German version of the palliative care outcome. J Pain Symptom Manage 30: 51–62

    Article  PubMed  Google Scholar 

  • — Bergman B, Aaronson N et al. (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC Core Quality of Life Questionnaire for use in lung cancer clinical trials. Eur J Cancer 30A, 635–42

    Article  PubMed  CAS  Google Scholar 

  • — Bruera E, Ripamonti C (1998) Dyspnea in Patients with Advanced Cancer in Supportive Oncology. Berger A, Portenoy R, Weissman D, ed., Lippincott-Raven, 295–308

    Google Scholar 

  • — Bundesarbeitsgemeinschaft für Rehabilitation (2003) Rahmenempfehlungen zur ambulanten onkologischen Rehabilitation. Bundesarbeitsgemeinschaft für Rehabilitation Frankfurt

    Google Scholar 

  • — Bunn PA, Lilenbaum R (2003) Chemotherapy for elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst, 5,95: 341–3

    Google Scholar 

  • — Cella D, Bonomi A et al. (1995) Reliability and validity of the functional assessment of cancer therapy-lung (Fact-L) quality of life instrument. Lung Cancer 12,3: 199–220

    Article  PubMed  CAS  Google Scholar 

  • — Cella D (1997) The functional assessment of cancer therapy anaemia (FACT-An) scale: A new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(suppl 2): 13–9

    PubMed  CAS  Google Scholar 

  • — Celli BR (2004) Chronic respiratory failure after lung resection: the role of pulmonary rehabilitation. Thorac Surg Clin 14,3: 417–28

    Article  PubMed  Google Scholar 

  • — Chanan A, Srinivasan S, Czuczman M (2004) Prevention and management of cardiotoxicity from antineoplastic therapy. J Support Oncol 2: 251–66

    Google Scholar 

  • — Colchen A, Gonin F, Bonnette P (2004) The place of interventional endoscopy in the treatment of lung cancer. Rev Pneumol Clin 60,3: 48–50

    Article  Google Scholar 

  • — Covey, A (2005) Management of malignant pleural effusions and ascites. J Support Oncol 3:169–76

    PubMed  Google Scholar 

  • — Delbrück H, Schmid L, Bartsch H et al. (2000) Zur Ergebnisqualität in der onkologischen Rehabilitation. Rehabilitation 39: 359–62

    Article  PubMed  Google Scholar 

  • — De Gregorio Ariza MA, Gamboa P, Gimeno M et al. (2003) Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 8: 252–63

    Google Scholar 

  • — Deschamps, Bernard A, Nichols C et al. (2001) Empyema and brochopleural fistula after pneumonectomy: Factors affecting incidence. Ann. Thorac Surg 72: 243–8

    Article  PubMed  CAS  Google Scholar 

  • — Donner CF (2006) Vocational rehabilitation and pulmonary programs. In: Gobelet C, Franchignoni F (Edit) Vocational rehabilitation Springer Paris 185–194

    Chapter  Google Scholar 

  • — Dorman U, Weis J, Bartsch HH (2006) Qualitätssicherung in der onkologischen Rehabilitation. Der Onkologe, Heidelberg (in Press)

    Google Scholar 

  • — Dubey S, Brown R, Esmond S et al. (2005) Patient preferences in choosing chemotherapy regiments for advanced non-small cell lung cancer. J Support Oncol 3: 149–54

    PubMed  Google Scholar 

  • — Dubois A, Schlaich M et al. (1999) Evaluation of neurotoxicity induced by paclitaxel second-line chemotherapy. Support Care cancer 7: 354

    Article  CAS  Google Scholar 

  • — Dunton JC (2002) Management of treatment-related toxicity in advanced ovarian cancer. Oncologist 7: 11–9

    Article  PubMed  CAS  Google Scholar 

  • — Earle C, Tsai JS, Gelber RD (2001) Effectiveness of chemotherapy for advanced lung cancer in the elderly. J Clin Oncol 19,4: 1064–70

    PubMed  CAS  Google Scholar 

  • — Edel H, Knauth K (1999) Grundzüge der Atemtherapie Urban & Fischer, München

    Google Scholar 

  • — ESMO (2001) Minimum clinical recommendations for diagnosis, treatment and follow-up of small-cell cancer. Ann Oncol 12: 1051

    Article  Google Scholar 

  • — ESMO (2001) Minimum clinical recommendations for diagnosis, treatment and follow-up of non small cell cancer. Ann Oncol 12: 1049

    Article  Google Scholar 

  • — Estfan B, LeGrand S (2004) Management of cough in advanced cancer. J Support Oncol 2: 523–7

    PubMed  Google Scholar 

  • — Freitag L (2004) Interventional endoscopic treatment. Lung Cancer 45,2: 235–8

    Article  Google Scholar 

  • — Fromme E, Eilers KM, Mori M et al. (2004) How accurate is clinician reporting of chemotherapy adverse effects? J Clin Oncol 22,17: 3485–90

    Article  PubMed  Google Scholar 

  • — Fryback D, Craig BM (2004) Measuring economic outcomes of cancer. J Natl Cancer Inst Monographs 33: 134–41

    Article  PubMed  Google Scholar 

  • — Gridelli C, Perrone F, Nelli F et al. (2001) Quality of life in lung cancer patients. Annals of oncology 12,3: 21

    Article  Google Scholar 

  • — Harada H, Okada M, Sakamoto T et al. (2005) Functional advantage after radical segmentectomy versus lobectomy for lung cancer. Ann Thorac Surg 80,6: 2041–5

    Article  PubMed  Google Scholar 

  • — Hill K, Amir Z et al. (2003) Do newly diagnosed lung cancer patients feel their concerns are being met? Eur J Cancer Care 12,1: 35–45

    Article  CAS  Google Scholar 

  • — Hollen P, Grall R et al. (1993) Quality of life assessment in individuals with lung cancer: Testing the Lung Cancer symptom Scale (LCSS). Eur J Cancer 29A,1: 551–8

    Google Scholar 

  • — Hopwood P, Stephens RJ (2000) Depression in patients with lung cancer: Prevalence and risk factors derived from quality of life data. J clin Oncol 18,4: 893–903

    PubMed  CAS  Google Scholar 

  • — Huisman C, Smit EF, Giaccone G et al. (2000) Second—line chemotherapy in relapsing or refractory non-small cell lung cancer: A review. J Clin Oncol 18: 3722–30

    PubMed  CAS  Google Scholar 

  • — Kelly K, Bunn J (1998) Is it time to reevaluate our approach to the treatment of brain metastases in patients with non-small-cell lung cancer? Lung cancer 20: 85–91

    Article  PubMed  CAS  Google Scholar 

  • — Korfee S, Gauler T, Hepp R et al. (2004) New targeted treatments in lung cancer — overview of clinical trials. Lung Cancer 45,2: 199–208

    Article  Google Scholar 

  • — Licker M, Spiliopoulos A, Frey J et al. (2005) Risk factors for early mortality and major complications following pneumonectomy for non small cell carcinoma of the lung. Chest 121: 1890–7

    Article  Google Scholar 

  • — Limper AH (2004) Chemotherapy-induced lung disease. Clin Chest Med 25: 53–64

    Article  PubMed  Google Scholar 

  • — Maguire P, Pitceathly C (2002) Key communication skills and how to aquire them. BMJ 325: 697–700

    Article  PubMed  Google Scholar 

  • — Maini C, Sciutu R, Romano L, Bergomi S (2003) Radionuclide therapy with bone seeking radionuclides in palliation of painful metastases. J Exp Clin Cancer Res 22,4: 71–4

    PubMed  CAS  Google Scholar 

  • — Mamon H, Wen PY, Loeffler JS (1999) Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation. Epilepsia 40(3): 341–4

    Article  PubMed  CAS  Google Scholar 

  • — Mancuso A, Migliorino M, de Santis S et al. (2006) Correlation between anemia and functional/cognitive capacity in elderly lung cancer patients treated with chemotherapy. Annals of oncoloy 17: 146–150

    Article  CAS  Google Scholar 

  • — Miller AB et al. (2004) Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 108: 269–76

    Article  PubMed  CAS  Google Scholar 

  • — Montazeri A, Gillis CR, McEwen J (1998) Quality of life in patients with lung cancer. Chest 113: 467–81

    Article  PubMed  CAS  Google Scholar 

  • — Muscarotili M, Bossola M, Aversa Z et al. (2006) Prevention and treatment of cancer cachexia: New insights into an old problem. Eurp J Cancer 42: 31–41

    Article  CAS  Google Scholar 

  • — Mutee F, Jatoi A (2006) Megestrol aceatate for the palliation of anorexia in advanced, incurable patients. Clin Nutr 6

    Google Scholar 

  • — Neuberger JS, Field RW (2003) Occupation and lung cancer in non smokers. Rev Environ Health 18,4: 251–67

    PubMed  Google Scholar 

  • — Paice J (2003) Mechanisms and management of neuropathic pain in cancer. J support Oncol 1,2: 107–14

    PubMed  Google Scholar 

  • — Pawel J, Schiller JH, Shepherd FA et al. (1999) Topotecan versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer. J Clin Oncol 17,2: 658

    Google Scholar 

  • — Pezner RD, Bertrand M, Cecchi G et al. (1984) Steroid-withdrawal radiation pneumonitis in cancer patients. Chest 85: 816–7

    Article  PubMed  CAS  Google Scholar 

  • — Ramsey SD, Howlader N, Etzioni RD et al. (2004) Chemotherapy use, outcomes, and costs for older persons with advanced non-small lung cancer. J Clin Oncol 22(24): 4971–8

    Article  PubMed  Google Scholar 

  • — Rizzo JD, Lichtin A et al. (2002) Use of epoetin in patients with cancer: Evidence-based clinical practice guidelines of the American society of clinical oncology and the American society of haematology. J Clin Oncol 20: 4083–4107

    Article  PubMed  CAS  Google Scholar 

  • — Robnett T, Machtay M, Vines EF et al. (2000) Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer. Int J Radiat Oncol Bio Phys 1,48, 1: 89–94

    Article  Google Scholar 

  • — Ron IG, Stav O, Vishne T et al. (2004) The correlation between palliation of bone pain by intravenous strontium 89 and external beam radiation to linked field in patients with osteoblastic bone metastases. Am J Clin Oncol 27(5): 5004

    Article  Google Scholar 

  • — Rosen LS, Gordon D, Tchekmedyian NS et al. (2004) Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with non-small-cell lung cancer and other solid tumours. Cancer 100,12: 2613–21

    Article  PubMed  CAS  Google Scholar 

  • — Schofield P, Ball D, Smith JG et al. (2004) Optimism and survival in lung carcinoma patients. Cancer 100,6: 1276–82

    Article  PubMed  Google Scholar 

  • — Seegenschmidt M (1998) Nebenwirkungen in der Onkologie. Springer, Berlin, Heidelberg, New York, Tokyo

    Google Scholar 

  • — Seute T, Leffers P, ten Velde GP et al. (2004) Neurologic disorders in 432 consecutive patients with small-cell lung carcinoma. Cancer 100: 801–6

    Article  PubMed  Google Scholar 

  • — Shepherd F, Pereira J, Ciuleanu T et al. (2005) Erlotinib in previously treated Non-small-cell lung cancer. N Engl J Med 353: 123–32

    Article  PubMed  CAS  Google Scholar 

  • — Sleijfer S (2001) Bleomycin-induced pneumonitis. Chest 120,2: 617–24

    Article  PubMed  CAS  Google Scholar 

  • — Spruit MA, Janssen PP, Willemsen SC et al. (2006) Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients. Lung Cancer (Mar)

    Google Scholar 

  • — Stanley H, Kelley K (2004) CNS home visits following diagnosis of lung cancer. Cancer Nursing Practice 3,2: 33–9

    Google Scholar 

  • — Stinnett H, S, Williams C, Johnson D (2007) Role of chemotherapy for palliation in the lung cancer patient. J Support Oncol 5,1: 19–24

    PubMed  CAS  Google Scholar 

  • — Sugimura, Yang H (2006) Long-term Survivorship in Lung Cancer*Chest. 129: 1088–97

    Article  PubMed  Google Scholar 

  • — Tamburini M. (2001) Health related quality of life measures in cancer. Ann Oncol 12(suppl 3): 7

    Article  Google Scholar 

  • — Thomas J, von Gunten C (2003) Management of dyspnea. J Support Oncol 1: 23–32

    PubMed  Google Scholar 

  • — Von Pawel J, Gatzemeier U, Pujol JL et al. (2001) Comparator of oral versus intravenous Topotecan in patients with chemosensitive small-cell lung cancer. J Clin Oncol 19: 1743–9

    Google Scholar 

  • — Wells M, Sarna L, Cooley M et al. (2007) Use of complementary and alternative medicine therapies to control symptoms in women living with lung cancer. Cancer Nurs 30,1: 45–55

    Article  PubMed  Google Scholar 

  • — Zatloukal P, Petrzelka L et al. (2004) Concurrent versus sequential chemo radiotherapy with cisplatin and vinorelbine in locally advanced non-small-cell lung cancer: A randomized study. Lung cancer 46,1: 87–98

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France, Paris

About this chapter

Cite this chapter

(2007). Rehabilitation and palliation of patients with bronchial cancer. In: Rehabilitation and palliation of cancer patients. Collection de L’Académie Européenne de Médecine de Réadaptation. Springer, Paris. https://doi.org/10.1007/978-2-287-72827-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-72827-3_12

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-72826-6

  • Online ISBN: 978-2-287-72827-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics